SCHEMBL30002520

SCHEMBL30002520

COc1cccc(F)c1-c1nc2c(cc1Cl)c1c(c(=O)n2-c2c(C)ccnc2C(C)C)NC(=O)[C@H]2CN(C(=O)O)[C@H](C)CN12

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KRAS P01116 20/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27154366 1.00 KRAS (0.55) KRAS
SCHEMBL29572675 0.93 KRAS (0.48) KRAS
SCHEMBL25414132 0.93 KRAS (0.48) KRAS
SCHEMBL25829878 0.93 KRAS (0.52) KRAS
SCHEMBL29963067 0.93 KRAS (0.52) KRAS
SCHEMBL29907439 0.93 KRAS (0.52) KRAS
SCHEMBL27149541 0.90 KRAS (0.52) KRAS
SCHEMBL31129086 0.89 KRAS (0.49) KRAS
SCHEMBL30109010 0.89 KRAS (0.55) KRAS
SCHEMBL27138934 0.89 KRAS (0.55) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022198904-A1 KEY INTERMEDIATE OF KRAS INHIBITOR AND PREPARATION METHOD THEREFOR 浙江海正药业股份有限公司 2022-09-29 WO disclosed
WO-2022199170-A1 TETRACYCLIC DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 浙江海正药业股份有限公司 2022-09-29 WO disclosed